{
    "Trade/Device Name(s)": [
        "AssureTech Secobarbital Strip",
        "AssureTech Oxycodone Strip",
        "AssureTech Secobarbital/Oxycodone Panel Dip",
        "AssureTech Secobarbital/Oxycodone Quick Cup",
        "AssureTech Secobarbital/Oxycodone Turn Key-Split Cup"
    ],
    "Submitter Information": "Assure Tech. Co., Ltd.",
    "510(k) Number": "K151211",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052115"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIS",
        "DJG"
    ],
    "Summary Letter Date": "April 3, 2015",
    "Summary Letter Received Date": "May 6, 2015",
    "Submission Date": "June 3, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3150",
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Barbiturate test system",
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Secobarbital",
        "Oxycodone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow"
    ],
    "Methodologies": [
        "Competitive binding",
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Strip",
        "Panel",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for AssureTech lateral flow urine tests for qualitative detection of Secobarbital and Oxycodone using immunochromatographic assay.",
    "Indications for Use Summary": "Qualitative detection of Secobarbital and/or Oxycodone in human urine for over-the-counter and prescription use, providing preliminary results to be confirmed by more specific chemical methods.",
    "fda_folder": "Toxicology"
}